Sites
Tags
- 3,4-Ethylidenedioxyamphetamine
- 3,4-Methylenedioxyphentermine
- Active metabolite
- Addictive
- Adrenergic agonist
- Adrenochrome
- Agonist
- Alcohol
- Aleph
- Aliphatic compound
- Almotriptan
- Alpha
- Alpha-Pyrrolidinopentiophenone
- AM-630
- AM-6545
- Amanita muscaria
- Amantadine
- American Society of Health-System Pharmacists
- Amfepramone
- Amineptine
- Amisulpride
- Amitriptyline
- Amoxapine
- Amphetamine
- Anorectic
- Anorexia
- Anticholinergic
- Antidepressant
- Antihistamine
- Anti-obesity medication
- Anxiety
- APICA
- Apomorphine
- Arbutamine
- Ariadne
- Aripiprazole
- Aromatic hydrocarbon
- Arylcyclohexylamine
- AS-19
- Ataxia
- Atomoxetine
- Atropine
- Atypical antipsychotic
- Avarengo
- Balance disorder
- Ball-and-stick model
- BDPC
- Beatrice
- Benactyzine
- Benzatropine
- Benzphetamine
- Benzylpiperazine
- Beta blocker
- Bethanidine
- Bimagrumab
- Biological half-life
- Biperiden
- Bob
- Bod
- BOH
- Borderline personality disorder
- Boxed warning
- Bretylium
- Bromocriptine
- Brompheniramine
- Bupropion
- Bupropion/naltrexone
- Buspirone
- Butane
- Butorphanol
- Cabergoline
- Cannabidiol
- Cannabinoid
- Cannabinoid receptor type 1
- Captodiame
- CAR-302,196
- Cardiac fibrosis
- Cariprazine
- Carvedilol
- CAS Registry Number
- Catecholamine
- Cathine
- Cathinone
- Château Léoville-Poyferré
- ChEBI
- Chemical formula
- ChemSpider
- Chirality
- Chlorofluorocarbon
- Chloroform
- Chlorphenamine
- Chlorpromazine
- Chlorprothixene
- Chordae tendineae
- Cinchonine
- Circulatory System
- Cisapride
- Clenbuterol
- Clinical trial
- Clomipramine
- Clozapine
- Cocaine
- Cognitive deficit
- Combination drug
- Come
- Committee for Medicinal Products for Human Use
- Constipation
- Controlled substance
- Controlled Substances Act
- CP 55,940
- Cyclizine
- Cyproheptadine
- DailyMed
- DALT
- DEA
- Deliriant
- Depression
- Deschloroketamine
- Desvenlafaxine
- Dexfenfluramine
- Dexmethylphenidate
- Dextroamphetamine
- Dextromethorphan
- Diário Oficial da União
- Diarrhea
- Dicycloverine
- Diethyl ether
- Dihydroergotamine
- Dimenhydrinate
- Dimethoxyamphetamine
- Dimethoxymethamphetamine
- Diphenhydramine
- Diphenidine
- Diprenorphine
- Dissociative
- Dizocilpine
- Dizziness
- Dobutamine
- DOI
- Dolasetron
- Dopamine
- Dopamine agonist
- Dopamine receptor D2
- Dopaminergic
- Dox
- Doxepin
- Doxylamine
- Dravet syndrome
- Dravet Syndrome Foundation
- Drooling
- Droxidopa
- DrugBank
- Drug nomenclature
- DSP-4
- Dysphoria
- EDMA
- Efavirenz
- Eletriptan
- Empathogen–entactogen
- Enantiomer
- Ephedra
- Ephedrine
- Ephenidine
- Epilepsy
- Epinephrine
- Erectile dysfunction
- Ergoline
- Ergotamine
- Esketamine
- Eszopiclone
- Ether
- Ethocybin
- Eticyclidine
- Euphoria
- European Chemicals Agency
- European Medicines Agency
- European Union
- Exenatide
- F-2
- F-22
- Falling
- Fatigue
- FDA
- Federal Register
- Fencamfamin
- Fenclonine
- Fenethylline
- Fenfluramine/phentermine
- Fenozolone
- Fenpropathrin
- Fever
- Flibanserin
- Fluorolintane
- Fluoxetine
- Fluphenazine
- Food and Drug Administration
- France
- Frovatriptan
- GABAA receptor
- Gait abnormality
- Galantamine
- Ganesha
- Gasoline
- Gastric inhibitory polypeptide
- Gepirone
- Glucagon-like peptide-1 receptor agonist
- Granisetron
- Hallucinogen
- Haloalkane
- Haloperidol
- Halothane
- Headache
- Heroin
- Hexacyclonate
- Hydroxyzine
- Hyoscine
- Hyoscyamine
- Hypertension
- Ibogaine
- Ibotenic acid
- Il Tuo
- Imipramine
- Inhalant
- Inhalational anaesthetic
- Insomnia
- International Chemical Identifier
- International Standard Book Number
- International Standard Serial Number
- Irritability
- Isoflurane
- Isoprenaline
- Jmol
- KEGG
- Kerosene
- Ketamine
- Ketotifen
- KHAT
- Lampa
- Lasmiditan
- Latrepirdine
- L-DOPA
- Lennox–Gastaut syndrome
- Lethargy
- Levoamphetamine
- Levomethamphetamine
- Levorphanol
- Levosalbutamol
- Liraglutide
- Lisdexamfetamine
- Lorcaserin
- Loxapine
- LSD
- Lurasidone
- Lysergic Acid Diethylamide
- Lysine
- Malaise
- Mancozeb
- Maprotiline
- Mazindol
- MBDB
- MDAT
- MDMA
- Mechanism of action
- Meclizine
- MedlinePlus
- Memantine
- Membrane transport protein
- Mephedrone
- Mepyramine
- Mescaline
- Metamfepramone
- Metaraminol
- Metformin
- Methamphetamine
- Methedrone
- Methoxetamine
- Methoxmetamine
- Methoxphenidine
- Methoxyketamine
- Methylbenzylpiperazine
- Methyldopa
- Methylergometrine
- Methylhexanamine
- Methylone
- Methylphenidate
- Methysergide
- Metoclopramide
- Mianserin
- Mirtazapine
- MMDA
- Molar mass
- Monoamine releasing agent
- Morphinan
- Morphine
- MPTP
- Muscarinic acetylcholine receptor
- Muscimol
- Nalbuphine
- Nalorphine
- Naltrexone
- Naratriptan
- Nausea
- N-Butanol
- NEFA
- Nefazodone
- Neurotoxicity
- Neurotransmission
- Neurotransmitter
- Nitrous oxide
- NMDA receptor
- NMDA receptor antagonist
- N-Methylphenethylamine
- N,N-Dimethyltryptamine
- Norepinephrine
- Norketamine
- Nortriptyline
- O-Acetylpsilocin
- Obesity
- Octodrine
- Olanzapine
- Ondansetron
- Oneirogen
- Opioid
- Optical rotation
- Oral administration
- Orciprenaline
- Orlistat
- Orphan drug
- Orphenadrine
- Overdose
- Oxaflozane
- Oxidopamine
- Oxprenolol
- Oxybutynin
- Oxyntomodulin
- Ozempic
- Paliperidone
- Palonosetron
- Panic Attack
- Para-Methoxy-N-ethylamphetamine
- Paraquat
- Pemoline
- Pentazocine
- Pergolide
- Pharmacokinetics
- Phases of clinical research
- Phencyclamine
- Phencyclidine
- Phenethylamine
- Phenibut
- Phenmetrazine
- Phenoxybenzamine
- Phentermine
- Phentermine/topiramate
- Phenylalanine
- Phenylephrine
- Phenylpropanolamine
- Pindolol
- Piperazine
- PMC
- Potency
- Pramipexole
- Precursor
- Pregnancy category
- Prenylamine
- Priority review
- Prochlorperazine
- Promethazine
- Propane
- Propranolol
- Proscaline
- Prucalopride
- Pseudoephedrine
- Psilocin
- Psilocybin
- Psychedelic drug
- Psychedelic experience
- Psychosis
- PubChem
- Public domain
- PubMed
- Pulmonary hypertension
- PX-2
- Quetiapine
- Racemic mixture
- Receptor modulator
- Regulation of therapeutic goods
- Rimonabant
- Risperidone
- Rizatriptan
- Rolicyclidine
- Rotenone
- Route of administration
- Salbutamol
- Salvinorin A
- Schizophrenia
- Sedation
- Seizure
- Selegiline
- Semaglutide
- Serotonin
- Serotonin syndrome
- Setmelanotide
- Sevoflurane
- Shortness of breath
- Sibutramine
- Side effect
- Sigma-1 receptor
- Sleep disorder
- Somnolence
- Status epilepticus
- Stimulant
- Structural analog
- STS-135
- Substituted amphetamine
- Substituted cathinone
- Substituted phenethylamine
- Substituted tryptamine
- Sumatriptan
- Symptom
- Synaptic vesicle
- Synthetic cannabinoids
- Tenocyclidine
- Tetrahydrocannabinol
- Tetrahydrocannabivarin
- THC-O-acetate
- The great
- Thioescaline
- Thioridazine
- Thujone
- Tirzepatide
- TOET
- Tolterodine
- Toluene
- Tom
- Topiramate
- Toxicity
- Tramadol
- Tranylcypromine
- Trazodone
- Tricyclic antidepressant
- Trifluoperazine
- Trifluoromethylphenylpiperazine
- Trihexyphenidyl
- Triprolidine
- Triptan
- Tryptamine
- Tuaminoheptane
- Typical antipsychotic
- Tyramine
- Tyrosine
- Uncoupling protein
- Upper respiratory tract infection
- Valerenic acid
- Valvular heart disease
- Venlafaxine
- Vilazodone
- Vomiting
- Vortioxetine
- Water
- Weakness
- Weight loss
- WHO Model List of Essential Medicines
- WIN 55,212-2
- Xenon
- Xerostomia
- Yohimbine
- Zaleplon
- Ziprasidone
- Zolmitriptan
- Zolpidem
- Zonisamide
- Zopiclone
- Κ-opioid receptor